Riskpilot← Back to searchSign inGet full accessABX HELSE AS
ASActiveOrg 924388919Storgata 32, 0184 OsloOther human health activities n.e.c. · NACE 8699Est. 20202 employees
Revenue 2024
NOK 0
EBITDA margin
—
-1% vs 2023
Equity ratio
-577.0%
Financial strength
Net profit 2024
NOK -254K
-1% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -254K | -1% |
| Net profit | NOK -254K | -1% |
| Total assets | NOK 94K | +806% |
| Equity | NOK -541K | -89% |
| Employees | 2 | — |
Legal name
ABX HELSE AS
Org number
924388919
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
21. januar 2020
Share capital
NOK 250 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Rådgivning og veiledning om sammenheng mellom livsstil og helse, og gjennomføring av aktiviteter innenfor folkehelse og helsefremmende tiltak, og andre produkter/tjenester som naturlig hører sammen med dette.
Address
Storgata 32, 0184 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 60 | 0 | 0 | 0 |
| Staff expenses | −0 | −51 | −0 | −68 | −137 | −150 |
| EBITDA | −0 | −95 | −90 | −100 | −251 | −254 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −0 | −95 | −90 | −100 | −251 | −254 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −0 | −95 | −90 | −100 | −251 | −254 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −0 | −95 | −90 | −100 | −251 | −254 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 100 | 596 | 184 | 45 | 10 | 94 |
| Equity | 100 | 55 | 64 | −35 | −287 | −541 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 542 | 119 | 80 | 297 | 635 |
| Total debt | 0 | 542 | 119 | 80 | 297 | 635 |
EBITDA margin
-25414600.0%
This company
15.8%
Market median
-160851999% vs market
20192024
Equity ratio
-577.0%
This company
38.2%
Market median
-1610% vs market
20192024
Return on equity
-25414600.0%
This company
18.4%
Market median
-138122926% vs market
20192024
Net profit margin
-25414600.0%
This company
8.1%
Market median
-313760594% vs market
20192024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192024
Debt / equity
1.17×
This company
0.62×
Market median
-89% vs market
20192024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JE Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Abx Sport Og Helse As | Company | 86.7% | 86.7% | 2022 |
| Individual | 13.3% | 13.3% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ABX HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Erasmus Dietrichson | Chief Executive Officer | 0 companies |
| Nina Christin Østgaard | Board of Directors | 0 companies |